Avidity Biosciences Webinar: EXPLORE44

A Clinical Trial Investigating the Potential for AOC 1044 to Treat Individuals with DMD Mutations Amenable to Exon 44 Skipping Join Cure Duchenne’s webinar as we welcome Kelly DiTrapani and […]

Fireside Chat with Dyne Therapeutics on DYNE-251

Moving from Bench to Clinic to Deliver a Potentially Transformative Therapy for Duchenne Muscular Dystrophy Join us for a Fireside Chat discussing Dyne’s Phase 1/2 clinical trial, DELIVER, evaluating DYNE-251 […]

Professional Webinar Series

Duchenne Research Pipeline Explained

The “What?”, “When?” and “How?” that everyone is asking.  This webinar will leave you with a better understanding of the different types of treatments and cures for Duchenne that are […]

Pfizer News Banner

Pfizer CIFFREO Webinar

Pfizer’s Global Clinical Lead for Rare Neurological Diseases, Beth Belluscio, MD-PhD, and Debra Miller, Founder and CEO of CureDuchenne, sat down to educate the Duchenne community on Pfizer’s CIFFREO Trial […]